Neurology 2000;55:940-946
© 2000 American Academy of Neurology
Articles
Magnetization transfer imaging to monitor the evolution of MS
A 1-year follow-up study
M. Filippi, MD,
M. Inglese, MD,
M. Rovaris, MD,
M. P. Sormani, PhD,
M. A. Horsfield, PhD,
G. Iannucci, MD,
B. Colombo, MD and
G. Comi, MD
From the Neuroimaging Research Unit (Drs. Filippi, Inglese, Rovaris, Sormani, and Iannucci) and the Clinical Trials Unit (Drs. Colombo and Comi), Department of Neuroscience, Scientific Institute Ospedale San Raffaele, University of Milan, Italy; and the Department of Medical Physics (Dr. Horsfield), University of Leicester, United Kingdom.
Address correspondence and reprint requests to Dr. Massimo Filippi, Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, Via Olgettina, 60, 20132 Milan, Italy.
OBJECTIVES: To assess the sensitivities of magnetization transfer imaging (MTI)-derived measures in detecting changes over time of macro- and microscopic lesion burdens in different MS phenotypes and to compare them with those of T2-weighted and T1-weighted lesion volumes.
METHODS: A total of 96 patients were studied: 39 with relapsing-remitting MS (RRMS), 19 with secondary progressive MS (SPMS), nine with primary progressive MS, and nine with benign MS; 20 with clinically isolated syndromes suggestive of MS at presentation; and 20 healthy subjects. Brain T2-weighted, T1-weighted, and MTI scans were obtained at baseline and after 12 months. The authors measured T2-weighted and T1-weighted lesion volumes and average lesion MT ratio (MTR). The authors also derived MTR histograms from whole brain tissue (WBT) and normal-appearing brain tissue (NABT).
RESULTS: In healthy control subjects, there was no significant change of any of the MTR histogram parameters. At follow-up, in the entire patient group, T2-weighted lesion volume significantly increased and average lesion MTR, WBT-MTR, NABT-MTR, and histogram peak positions significantly decreased. Patients with RRMS and SPMS had significantly higher changes in T2-weighted lesion volume and all the MTI-derived metrics compared with the other subgroups. MTI changes were more prominent (and significantly different) in patients with SPMS than in those with RRMS. Compared with patients with benign MS, patients with RRMS had significantly greater changes in T2-weighted lesion volume and WBT- and NABT-MTR metrics. Compared with patients with SPMS, patients with primary progressive MS had similar changes of T1-weighted and T2-weighted lesion volumes, but significantly lower changes of MTI-derived measures.
CONCLUSIONS: MTI-derived measures are sensitive for detecting MS-related changes and might provide valuable outcome measures when assessing treatment effects in clinical trials of patients with MS.
This article has been cited by other articles:

|
 |

|
 |
 
A Ceccarelli, M Filippi, M Neema, A Arora, P Valsasina, M. Rocca, B. Healy, and R Bakshi
T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis
Multiple Sclerosis,
June 1, 2009;
15(6):
678 - 686.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rovaris, F. Barkhof, M. Calabrese, N. De Stefano, F. Fazekas, D. H. Miller, X. Montalban, C. Polman, M. A. Rocca, A. J. Thompson, et al.
MRI features of benign multiple sclerosis: Toward a new definition of this disease phenotype
Neurology,
May 12, 2009;
72(19):
1693 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Tallantyre, L. Bo, O. Al-Rawashdeh, T. Owens, C. H. Polman, J. Lowe, and N. Evangelou
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease
Brain,
May 1, 2009;
132(5):
1190 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Amato, E. Portaccio, M. L. Stromillo, B. Goretti, V. Zipoli, G. Siracusa, M. Battaglini, A. Giorgio, M. L. Bartolozzi, L. Guidi, et al.
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
Neurology,
August 26, 2008;
71(9):
632 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Bar-Zohar, F Agosta, D Goldstaub, and M Filippi
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Multiple Sclerosis,
July 1, 2008;
14(6):
719 - 727.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Di Perri, M. Battaglini, M. L. Stromillo, M. L. Bartolozzi, L. Guidi, A. Federico, and N. De Stefano
Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple Sclerosis
Arch Neurol,
February 1, 2008;
65(2):
236 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pulizzi, M. Rovaris, E. Judica, M. P. Sormani, V. Martinelli, G. Comi, and M. Filippi
Determinants of Disability in Multiple Sclerosis at Various Disease Stages: A Multiparametric Magnetic Resonance Study
Arch Neurol,
August 1, 2007;
64(8):
1163 - 1168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vrenken, P.J.W. Pouwels, S. Ropele, D.L. Knol, J.J.G. Geurts, C.H. Polman, F. Barkhof, and J.A. Castelijns
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease
Multiple Sclerosis,
July 1, 2007;
13(6):
708 - 716.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Benedetti, D.J. Rigotti, S. Liu, M. Filippi, R.I. Grossman, and O. Gonen
Reproducibility of the Whole-Brain N-Acetylaspartate Level across Institutions, MR Scanners, and Field Strengths
AJNR Am. J. Neuroradiol.,
January 1, 2007;
28(1):
72 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Agosta, M. Rovaris, E. Pagani, M. P. Sormani, G. Comi, and M. Filippi
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis
Brain,
October 1, 2006;
129(10):
2620 - 2627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vrenken, J. J. G. Geurts, D. L. Knol, L. N. van Dijk, V. Dattola, B. Jasperse, R. A. van Schijndel, C. H. Polman, J. A. Castelijns, F. Barkhof, et al.
Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter
Radiology,
September 1, 2006;
240(3):
811 - 820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. De Stefano, M. Battaglini, M. L. Stromillo, V. Zipoli, M. L. Bartolozzi, L. Guidi, G. Siracusa, E. Portaccio, A. Giorgio, S. Sorbi, et al.
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
Brain,
August 1, 2006;
129(8):
2008 - 2016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ge
Multiple Sclerosis: The Role of MR Imaging
AJNR Am. J. Neuroradiol.,
June 1, 2006;
27(6):
1165 - 1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vrenken, S.A.R.B. Rombouts, P.J.W. Pouwels, and F. Barkhof
Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.
AJNR Am. J. Neuroradiol.,
April 1, 2006;
27(4):
868 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al.
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Arch Neurol,
April 1, 2006;
63(4):
614 - 619.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Dalton, K. A. Miszkiel, P. W. O'Connor, G. T. Plant, G.P.A. Rice, and D. H. Miller
Ventricular enlargement in MS: One-year change at various stages of disease
Neurology,
March 14, 2006;
66(5):
693 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. M. Fernando, D. J. Tozer, K. A. Miszkiel, R. M. Gordon, J. K. Swanton, C. M. Dalton, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller
Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis
Brain,
December 1, 2005;
128(12):
2911 - 2925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Filippi, M. A. Rocca, E. Pagani, G. Iannucci, M. P. Sormani, F. Fazekas, S. Ropele, O. R. Hommes, and G. Comi
European Study on Intravenous Immunoglobulin in Multiple Sclerosis: Results of Magnetization Transfer Magnetic Resonance Imaging Analysis
Arch Neurol,
September 1, 2004;
61(9):
1409 - 1412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Q. Zhou, Y. M. Zhu, J. Grimaud, M. Hermier, M. Rovaris, and M. Filippi
A New Method for Analyzing Histograms of Brain Magnetization Transfer Ratios: Comparison with Existing Techniques
AJNR Am. J. Neuroradiol.,
August 1, 2004;
25(7):
1234 - 1241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. M. Fernando, M. A. McLean, D. T. Chard, D. G. MacManus, C. M. Dalton, K. A. Miszkiel, R. M. Gordon, G. T. Plant, A. J. Thompson, and D. H. Miller
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
Brain,
June 1, 2004;
127(6):
1361 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Filippi, M. Rovaris, and M. A Rocca
Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques
Multiple Sclerosis,
June 1, 2004;
10(1_suppl):
S36 - S45.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Filippi, M. Rovaris, and M. A Rocca
Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques
Multiple Sclerosis,
May 1, 2004;
10(3_suppl):
S36 - S45.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Schmierer, D. R Altmann, N. Kassim, H. Kitzler, C. M Kerskens, C. A Doege, O. Aktas, J. D Lunemann, D. H Miller, F. Zipp, et al.
Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study
Multiple Sclerosis,
April 1, 2004;
10(2):
182 - 187.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cassol, J.-P. Ranjeva, D. Ibarrola, C. Mekies, C. Manelfe, M. Clanet, and I. Berry
Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter
Multiple Sclerosis,
April 1, 2004;
10(2):
188 - 196.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rovaris, F. Agosta, M. P. Sormani, M. Inglese, V. Martinelli, G. Comi, and M. Filippi
Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study
Brain,
October 1, 2003;
126(10):
2323 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inglese, J.H.T.M. van Waesberghe, M. Rovaris, K. Beckmann, F. Barkhof, D. Hahn, L. Kappos, D.H. Miller, C. Polman, C. Pozzilli, et al.
The effect of interferon {beta}-1b on quantities derived from MT MRI in secondary progressive MS
Neurology,
March 11, 2003;
60(5):
853 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inglese, N. DeStefano, E. Pagani, M. T. Dotti, G. Comi, A. Federico, and M. Filippi
Quantification of Brain Damage in Cerebrotendinous Xanthomatosis with Magnetization Transfer MR Imaging
AJNR Am. J. Neuroradiol.,
March 1, 2003;
24(3):
495 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rovaris, M. A Rocca, and M. Filippi
Magnetic resonance-based techniques for the study and management of multiple sclerosis
Br. Med. Bull.,
March 1, 2003;
65(1):
133 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Filippi and R. I. Grossman
MRI techniques to monitor MS evolution: The present and the future
Neurology,
April 23, 2002;
58(8):
1147 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Guo, V. L. Jewells, and J. M. Provenzale
Analysis of Normal-Appearing White Matter in Multiple Sclerosis: Comparison of Diffusion Tensor MR Imaging and Magnetization Transfer Imaging
AJNR Am. J. Neuroradiol.,
November 1, 2001;
22(10):
1893 - 1900.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|